Vulnerability · CVE-2024-52890
IBM Engineering Lifecycle Optimization - Publishing 7.0.2 and 7.03 could be susceptible to cross-site scripting due to no validation of URIs.
Published Aug 5, 2025 · catalog updated Aug 5, 2025 · IBM IBM Engineering Lifecycle Optimization - Publishing
Last checked Oct 29, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2024-52890. EPSS is 0.20%. Act only if a listed version of IBM IBM Engineering Lifecycle Optimization - Publishing is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium6.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.20%
- Remediation
- Vendor / distro source
- Affected products
- vendor IBM IBM Engineering Lifecycle Optimization - Publishing 7.0.3
IBM Engineering Lifecycle Optimization - Publishing 7.0.2 and 7.03 could be susceptible to cross-site scripting due to no validation of URIs.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor IBM IBM Engineering Lifecycle Optimization - Publishing 7.0.37.0.3
How to fix CVE-2024-52890
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
Seen in 7.0.3
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2024-52890. EPSS is 0.20%. Act only if a listed version of IBM IBM Engineering Lifecycle Optimization - Publishing is installed.
Which versions are affected?
Compare what you have installed with IBM IBM Engineering Lifecycle Optimization - Publishing 7.0.3 7.0.3. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.20%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Aug 5, 2025 · EUVD
Detected
IBM Engineering Lifecycle Optimization - Publishing 7.0.2 and 7.03 could be susceptible to cross-site scripting due to no validation of URIs.
Aug 5, 2025 · EUVD
Updated
IBM Engineering Lifecycle Optimization - Publishing 7.0.2 and 7.03 could be susceptible to cross-site scripting due to no validation of URIs.
Sources
- CVE.orgVulnerability recordCVE-2024-52890
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2024-52890
30-day exploitation probability 0.20%
first.org - EUVDVulnerability recordEUVD-2024-54848
IBM Engineering Lifecycle Optimization - Publishing 7.0.2 and 7.03 could be susceptible to cross-site scripting due to no validation of URIs.
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 29, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSOct 29, 2026
- CVE.orgOct 21, 2026
- EUVDOct 20, 2026